Barbon V - Search Results

1

Capsule enteroscopy vs. other diagnostic procedures in diagnosing obscure gastrointestinal bleeding: a cost-effectiveness study.

Marmo R, Rotondano G, Rondonotti E, de Franchis R, D'Incà R, Vettorato MG, Costamagna G, Riccioni ME, Spada C, D'Angella R, Milazzo G, Faraone A, Rizzetto M, Barbon V, Occhipinti P, Saettone S, Iaquinto G, Rossini FP; Club Italiano Capsula Endoscopica - CICE. Marmo R, et al. Among authors: barbon v. Eur J Gastroenterol Hepatol. 2007 Jul;19(7):535-42. doi: 10.1097/MEG.0b013e32812144dd. Eur J Gastroenterol Hepatol. 2007. PMID: 17556898

2

Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine.

Gaia S, Barbon V, Smedile A, Olivero A, Carenzi S, Lagget M, Alessandria C, Rizzetto M, Marzano A. Gaia S, et al. Among authors: barbon v. J Hepatol. 2008 Apr;48(4):540-7. doi: 10.1016/j.jhep.2007.12.018. Epub 2008 Jan 31. J Hepatol. 2008. PMID: 18279995

3

Acute small-bowel perforation secondary to capsule endoscopy.

Repici A, Barbon V, De Angelis C, Luigiano C, De Caro G, Hervoso C, Danese S, Preatoni P, Pagano N, Comunale S, Pennazio M, Rizzetto M. Repici A, et al. Among authors: barbon v. Gastrointest Endosc. 2008 Jan;67(1):180-3. doi: 10.1016/j.gie.2007.05.044. Epub 2007 Nov 5. Gastrointest Endosc. 2008. PMID: 17981271 No abstract available.

4

Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B patients completely responders during 5 years of therapy.

Barbon V, Gaia S, Marzano A, Lagget M, Rizzetto M. Barbon V, et al. J Hepatol. 2004 Sep;41(3):500-1. doi: 10.1016/j.jhep.2004.04.018. J Hepatol. 2004. PMID: 15336458 No abstract available.

5

Panenteric IBD-like disease in a patient with regressive autism shown for the first time by the wireless capsule enteroscopy: another piece in the jigsaw of this gut-brain syndrome?

Balzola F, Barbon V, Repici A, Rizzetto M, Clauser D, Gandione M, Sapino A. Balzola F, et al. Among authors: barbon v. Am J Gastroenterol. 2005 Apr;100(4):979-81. doi: 10.1111/j.1572-0241.2005.41202_4.x. Am J Gastroenterol. 2005. PMID: 15784047 No abstract available.

6

Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B.

Gaia S, Marzano A, Smedile A, Barbon V, Abate ML, Olivero A, Lagget M, Paganin S, Fadda M, Niro G, Rizzetto M. Gaia S, et al. Among authors: barbon v. Aliment Pharmacol Ther. 2004 Aug 1;20(3):281-7. doi: 10.1111/j.1365-2036.2004.02073.x. Aliment Pharmacol Ther. 2004. PMID: 15274664 Free article.

7

Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness.

Poli E, Barbon V, Lucchetta S, Cattelan M, Santoro L, Zin A, Milano GM, Zanetti I, Bisogno G, Bonvini P. Poli E, et al. Among authors: barbon v. Oncoimmunology. 2022 Jul 6;11(1):2096349. doi: 10.1080/2162402X.2022.2096349. eCollection 2022. Oncoimmunology. 2022. PMID: 35813575 Free PMC article.

8

On the efficacy of macrolide-based therapy for Helicobacter pylori infection.

Barbon V. Barbon V. Panminerva Med. 2009 Mar;51(1):51; author reply 51-2. Panminerva Med. 2009. PMID: 19352310 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters